CIK 0001824893 · Non-accelerated filer<br>Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 301374889
- Phone
- 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-24 | Parker Craig C Chief Executive Officer | Returned to the company · Series C Common Stock Warrant (right to buy) | −5,712 | 0 | ||
| 2025-03-24 | Parker Craig C Chief Executive Officer | Returned to the company · Series D Common Stock Warrant (right to buy) | −5,712 | 0 | ||
| 2025-03-24 | Parker Craig C Chief Executive Officer | Grant or award · Series A Common Stock Warrant (right to buy) | +1,474 | 1,474 | ||
| 2025-03-24 | Parker Craig C Chief Executive Officer | Grant or award · Series B Common Stock Warrant (right to buy) | +1,603 | 1,603 | ||
| 2025-01-17 | Parker Craig C Chief Executive Officer | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2025-01-17 | Li Yang Exec. Vice President, Research | Grant or award · Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-17 | Williams Charles O CFO and COO | Grant or award · Option (right to buy) | +45,000 | 45,000 | ||
| 2025-01-03 | Li Yang Exec. Vice President, Research | Sale | −843 | $17.37 | $15K | 13,345 |
| 2025-01-03 | Williams Charles O CFO and COO | Sale | −1,181 | $17.37 | $21K | 8,982 |
| 2025-01-02 | Li Yang Exec. Vice President, Research | Option exercise | +2,500 | 14,188 | ||
| 2025-01-02 | Williams Charles O CFO and COO | Option exercise | +3,500 | 10,163 | ||
| 2024-06-14 | Li Yang Exec. Vice President, Research | Grant or award | +400 | $5.67 | $2K | 10,888 |
| 2024-06-14 | Williams Charles O CFO and COO | Grant or award | +400 | $5.67 | $2K | 5,863 |
| 2024-06-14 | Parker Craig C Chief Executive Officer | Grant or award | +400 | $5.67 | $2K | 5,824 |
| 2024-06-05 | WOODHOUSE DAVID J Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2024-06-05 | Lin Shao-Lee Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2024-06-05 | Rothenberg Mace Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2024-06-05 | Kutzkey Tim Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2024-06-05 | Haak-Frendscho Mary Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2024-06-05 | CHAI CHRISTOPHER Y Director | Grant or award · Option (right to buy) | +1,333 | 1,333 |
Page 9 of 12 · 237 trades